GeneDx Holdings Corp (WGS)
21.03
-0.73
(-3.35%)
USD |
NASDAQ |
May 21, 15:01
GeneDx Holdings Free Cash Flow: -146.69M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -146.69M |
| December 31, 2023 | -185.86M |
| September 30, 2023 | -221.12M |
| June 30, 2023 | -272.42M |
| March 31, 2023 | -304.09M |
| Date | Value |
|---|---|
| December 31, 2022 | -333.48M |
| September 30, 2022 | -325.66M |
| June 30, 2022 | -307.58M |
| March 31, 2022 | -249.42M |
| December 31, 2021 | -211.22M |
Free Cash Flow Range, Past 5 Years
-333.48M
Minimum
Dec 2022
-146.69M
Maximum
Mar 2024
-255.75M
Average
-260.92M
Median
Free Cash Flow Benchmarks
| American Well Corp | -190.32M |
| GoodRx Holdings Inc | 86.50M |
| Privia Health Group Inc | 61.03M |
| Doximity Inc | 178.30M |
| GE HealthCare Technologies Inc | 1.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.41M |
| Cash from Investing (Quarterly) | 0.843M |
| Cash from Financing (Quarterly) | -0.438M |
| Free Cash Flow Per Share (Quarterly) | -0.6468 |
| Free Cash Flow to Equity (Quarterly) | -15.96M |
| Free Cash Flow to Firm (Quarterly) | -16.26M |
| Free Cash Flow Yield | -27.04% |